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Abstract
Background: We compared the proportion of ischemic heart disease (IHD) patients newly diagnosed with dementia and
depression across three treatment groups: percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG)
and medical management alone (IHD-medical).
Methods and Findings: De-identified, individual-level administrative records of health service use for the population of
Manitoba, Canada (approximately 1.1 million) were examined. From April 1, 1993 to March 31, 1998, patients were identified
with a diagnosis of IHD (ICD-9-CM codes). Index events of CABG or PCI were identified from April 1, 1998 to March 31, 2003.
Outcomes were depression or dementia after the index event. Patients were followed forward to March 31, 2006 or until
censored. Proportional hazards regression analysis was undertaken. Independent variables examined were age, sex,
diabetes, hypertension and income quintile, medical management alone for IHD, or intervention by PCI or CABG. Age, sex,
diabetes, and presence of hypertension were all strongly associated with the diagnosis of depression and dementia. There
was no association with income quintile. Dementia was less frequent with PCI compared to medical management;
(HR=0.65; p=0.017). CABG did not provide the same protective effect compared to medical management (HR=0.90;
p=0.372). New diagnosis depression was more frequent with interventional approaches: PCI (n=626; hazard ratio=1.25;
p=0.028) and CABG (n=1124, HR=1.32; p=0.0001) than non-interventional patients (n=34,508). Subsequent CABG was
nearly 16-fold higher (p,0.0001) and subsequent PCI was 22-fold higher (p,0.0001) for PCI-managed than CABG-managed
patients.
Conclusions: Patients managed with PCI had the lowest likelihood of dementia—only 65% of the risk for medical
management alone. Both interventional approaches were associated with a higher risk of new diagnosed depression
compared to medical management. Long-term myocardial revascularization was superior with CABG. These findings
suggest that PCI may confer a long-term protective effect from dementia. The mechanism(s) of dementia protection
requires elucidation.
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Introduction
A long-standing controversy exists as to the extent of neurological
deterioration with surgical management of ischemic heart disease
(IHD) [1–7]. Cognitive impairment, if it occurs, and progression to
dementia remains poorly delineated. A confounder is that in elderly
patients with IHD, early dementia may be misdiagnosed as new
onset depression [8]. A further confounder is that depression may in
turnaffect the courseofIHD[9–11]. Also unclear fromthe available
literature is whether or not percutaneous coronary intervention
(PCI) has a different likelihood of, or any, long-term neurological
complications. In a broader sense, controversy also exists as to
whether or not IHD itself causes cognitive deterioration [12–20].
Some recent evidence indicates that impaired cardiac output is a
potential risk factor for abnormal brain aging [21,22]. Interventions
to revascularize the heart, thereby improving cardiac performance,
could potentially slow cerebral deterioration over time.
Knowledge of the relationship of dementia and depression to
the various management approaches for IHD would be of value to
counsel cardiac patients regarding long-term survival and quality
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17457of life. The questions to consider are whether interventional
approaches are more likely to precipitate cognitive decline than
medical management, and if so, is PCI associated with lower risk
of poor outcomes than the more invasive open-heart procedures
with cardiopulmonary bypass?
In an attempt to answer these questions we have undertaken a
population-based longitudinal comparison of the approach to
management of IHD using data at the Manitoba Centre for
Health Policy in Winnipeg, Canada. We have compared the
proportion of dementia and depression in patients with previously
diagnosed IHD in three groups; 1) managed by medical therapy
alone; 2) managed by insertion of either bare metal or drug-eluting
stents by PCI or; 3) managed by open-heart surgery with
cardiopulmonary bypass.
Methods
Approvals
This study was approved by the Health Research Ethics Board
of the University of Manitoba and the Health Information Privacy
Committee of Manitoba Health. The Manitoba Centre for Health
Policy works within the provisions of the Manitoba Freedom of
Information and Protection of Privacy Act (FIPPA) and the
Manitoba Personal Health Information Act (PHIA). Researchers
do not seek individual consent to use these data for research and
statistical purposes. Such use is permitted by legislation for
approved research, policy formulation and/or statistical purposes.
Data source
This study used de-identified, individual-level administrative
records of health service use for the entire population of Manitoba,
Canada (approx 1.1 million). The province of Manitoba provides
all residents with comprehensive coverage for medical and hospital
care without co-payment, as well as other health services. The
research data system, housed in the repository of the Manitoba
Centre for Health Policy, has been extensively validated and
described elsewhere [23].
Patient selection
Only residents age 40 years or older were included. IHD cases
were identified in the five-year period from April 1, 1993 to March
31, 1998 using a definition validated by Lix et al. [24]. If a resident
was hospitalized in that period and received an ICD-9-CM
diagnosis between 410–414 (in any of 16 diagnosis fields), they
were identified as an IHD case. Medical claims were also used to
identify cases, using four overlapping two-year windows: if within
any two-year period a resident had two physician visits coded with
ICD-9-CM 410-414, they were identified as an IHD case.
Duplicates were removed, and patients were considered IHD
cases as of the first date they met either criterion. This process
identified 57,473 IHD cases. We then removed patients who
received any of the procedures to be examined (PCI or CABG), to
eliminate the possibility that the index procedure (occurring after
April 1, 1998) was not itself a subsequent procedure. We also
excluded any patients with existing diagnosed dementia or
depression. Dementia was defined from hospital abstract data or
physician visits as any of the following ICD-9-CM diagnoses:
290.0-290.9, 291.1, 291.2, 292.82, 292.83, 294.0, 294.1, 294.8,
294.9, 331.0, 331.1, 331.7, 331.9, 797, or 799.3 [25]. Depression
was diagnosed with the codes 296.2–296.8, 300.4, 309, or 311
[25]. A comprehensive report of these techniques described in
‘‘Patterns of Regional Mental Illness Disorder Diagnoses and
Service Use in Manitoba: A Population-Based Study’’ is available
[26]. See CONSORT diagram for cohort selection (Figure 1).
Interventional cases
Records for all IHD cases were examined over the subsequent
five-year period (April 1, 1998 through March 31, 2003) to track
all cases receiving PCI or CABG procedures. PCI was defined as
ICD-9-CM procedure codes 36.01, 36.02, 36.05, or 36.06; CABG
was defined as any ICD-9-CM code 36.10-36.14 or 36.19. The
first procedure in the period was taken as the ‘index’ procedure,
and the case was assigned to that group; repeat/subsequent
procedures were also tracked for post-hoc comparison.
Outcomes
IHD cases comprising medical management alone, PCI or
CABG cases were followed forward from the date of their
procedure until March 31, 2006 (or death or loss to follow-up) to
determine rates of onset of dementia or depression.
Data Analysis
Proportional hazards regression analyses were conducted on
time to diagnosis of depression and time to diagnosis of dementia,
with the entire cohort of IHD cases who met the criteria described
above. These models also included age, sex, diabetes and
hypertension status, and income quintile (area-level average
household income from the Canadian Census) as covariates.
Patients were followed from the date of IHD diagnosis, until
diagnosis of dementia or depression, or censoring because of
death, loss to follow-up, a subsequent procedure, or the study end
date (March 31, 2006). PCI status and CABG status were included
as time varying covariates, such that all patients in the cohort
began in the IHD group and crossed over into a treatment group
at the index date of the treatment. Frequency data were compared
between groups by x
2-tests of independence or Poisson regression.
A Bonferroni correction was applied to secondary outcomes,
which were considered significant at p,0.025.
Results
The CONSORT diagram for selection criteria to the final
patient cohort studied is shown in Figure 1.
The summary of patient characteristics is shown in Table 1.
The largest group analyzed, by considerable margin, was the IHD-
medical management group (n=34,508) compared to PCI
(n=629) and CABG (n=1124). The mean age was greater for
the non-intervened group by 7–8 years. No difference in age was
seen between the PCI or CABG groups. Male patients were more
numerous in the intervened groups. Diabetes was least prevalent in
the non-intervened group. Hypertension was more common in the
intervened groups.
The proportion of patients newly diagnosed with dementia was
4.9% for the PCI group, 7.0% for the CABG group and 12.1% for
the medical management group. The mean follow-up times for the
diagnosis of new dementia were 4.7, 5.2 and 4.9 years respectively
(min-max; 0–8 years for all). The proportion of patients newly
diagnosed with depression was 16.4% for PCI, 18.8% for CABG
and 16.9% for IHD-medical management. The mean follow-up
times for new depression was 4.3 years for PCI; 4.8 years for
CABG and 4.6 years for IHD-medical management (min-max; 0–
8 years for all).
To control for differences in covariates described above,
proportional hazards regression was undertaken to allow unbiased
comparisons for the likelihood of new depression and dementia for
each of the studied IHD treatment modalities. Standard
assumptions behind proportional hazards regression modelling
were met before proceeding with the analyses.
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dementia is shown in Table 2. Age, female sex, presence of diabetes
and hypertension, were all highly correlated with a diagnosis of
dementia. The most influential variable in the model for dementia
was age (x
2=1636) followed by hypertension (x
2=1012) and
diabetes (x
2=233), as expected. The hazard ratio for age was 1.07,
indicating advancing age was associated with proportionately
greater dementia. Hypertension was associated with the greatest
hazard ratio at 2.93. There was no association of income quintile
with dementia. Of all patients studied, 4310 were diagnosed with
new dementia for an overall proportion of 11.9% for the full cohort
analyzed in the proportional hazards regression model.
The proportional hazards regression related to new depression
is shown in Table 3. Age, presence of diabetes, hypertension,
female sex were all highly correlated with a diagnosis of new
depression. The hazard ratio was less than 1.0 for age, indicating
advancing age was associated with a proportionally lower rate of
depression. There was no association of income quintile with new
depression. Of all patients studied, 6215 were diagnosed with new
depression for an overall proportion of 17.1% for the complete
cohort analyzed in the proportional hazards regression model.
Table 4 shows proportional hazard ratios for dementia and
depression based on IHD treatment modality. An overall test of
Figure 1. CONSORT Diagram for Cohort Selection.
doi:10.1371/journal.pone.0017457.g001
Table 1. Summary of Patient Characteristics.
Covariate PCI CABG
IHD
Medical
Chi-square
p-value
n=629 n=1124 n=34508
Age (%)
Mean Age (yr) 67.3 66.9 74.1 p,0.0001
Median Age (yr) 68 68 75
Sex (%)
Male 69.6 78.3 56.7 p,0.0001
Female 30.4 21.7 43.3
Diabetes (%)
No 72.7 65.0 83.0 p,0.0001
Yes 27.3 35.1 17.0
Hypertension (%)
No 38.6 33.4 56.4 p,0.0001
Yes 61.4 66.6 43.6
doi:10.1371/journal.pone.0017457.t001
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diagnosis of dementia (x
2=6.05, p=0.048). Pairwise comparisons
revealed that intervention with PCI was associated with a lower
likelihood of dementia than for medical management alone
(HR=0.65; p=0.017). No sparing effect for dementia was seen
with CABG compared to medical management (HR=0.90;
p=0.37). PCI vs CABG showed a trend for less dementia with
PCI (HR=0.74; p=0.15). The overall test of treatment type for
diagnosis of new depression was also significant (x
2=19.7,
p,0.0001). Both interventional approaches resulted in increased
risk of new depression. The HR was 1.32 for CABG (p,0.0001)
and 1.26 for PCI (p=0.028). There was no significant difference
between CABG and PCI interventions.
When comparing the two interventional groups there was a
markedly different requirement for further cardiac interventions.
Subsequent CABG was required in 6.3% of the patients receiving
PCI as their initial intervention, nearly 16-fold greater than the
0.4% seen for patients initially revascularized with bypass surgery;
(x
2=25.4; p,0.0001). Close to a third of patients with an index
PCI also required re-intervention with follow-up PCI (29%)
compared to 1.3% in patients who had an index CABG (a 22-fold
difference; x
2=143; p,0.0001).
Death rate was 27.3% in the PCI group, 25.8% in the CABG
group and 31.1% in the IHD medical group. The percent lost to
follow up was 3.2% in the PCI group; 2.9% in the CABG group
and 2.1% in the IHD medical group.
Discussion
The principal new finding of this population-based longitudinal
study of patients with documented IHD is that a follow-up
diagnosis of dementia is less frequent with PCI as the
interventional approach when compared to medical management
alone. The hazard ratio for PCI as the treatment for IHD was
0.65; 95% CI: 0.46 and 0.84; p=0.017. CABG did not confer
such an advantage (HR=0.90; p=0.372). Both interventional
approaches were associated with an increased risk of a diagnosis of
new depression compared to medical management alone. That
PCI as a treatment for IHD could impact on dementia risk was
unexpected. Our a priori hypothesis was that patients undergoing
CABG would be at greater risk of dementia than either patients
managed with PCI or medical management – based on a number
of studies examining cognitive dysfunction after open-heart
surgery. Stated causes for increased risk of cognitive cerebral
injury with open heart surgery – especially on-pump procedures –
includes embolic deposition to the brain (air or particulate matter),
blood pressure fluctuations, non-physiological pulsation during
extracorporeal perfusion, activation of the inflammatory cascade
due to blood elements contacting non-endothelialized surfaces and
altered cerebral oxygenation, among others [27–29]. Embolic risk
– although of lesser magnitude – is also present with PCI as
retrograde cannulation through the aorta is required for this
procedure. This lower but non-zero risk, could in theory, be
hypothesized to result in a higher risk of cognitive impairment in
this group compared to medically managed patients, whereas our
findings indicate the opposite.
We compared our 3 groups for onset of new depression after
their diagnosis of IHD because dementia is often not recognized in
its earliest stages. One of our hypotheses was that physicians may
misdiagnose mild dementia as depression. When patients with
severe dementia are seen, a false diagnosis is less likely. Our
examination of both depression and dementia was expected to
capture those with certain dementia and those with more subtle
changes. The reliability of using administrative data to differen-
tiate Alzheimer’s disease, vascular dementia or mixed dementia is
questionable. Our definition under-estimates dementia cases to
some degree, most likely the milder forms which can be more
challenging to detect.
Concern could be raised about whether truly representative groups
were selected to examine the proportion of dementia and depression
from the total of 57,473 patients with IHD that were identified.
However the proportional rate of dementia and depression in the
exclusion group expressed as a percentage of the total population was
10.3% and 20.5%—similar to our results in the IHD medical group.
We cede that with administrative data diagnostic criteria are more
difficult to establish, and this lack of clinical correlates results in
uncertainty about the appropriateness of treatment or non-treatment
of patients. Also unexamined were the effects of obesity and smoking
history on depression and dementia as there are no ICD-9 or -10
codes for these important covariates. As with all studies based on
administrative data there is a lag time. Our data are inclusive to as
recent as March 31, 2006. Current updates to clinical practice could
have an impact on the findings as discussed.
The mechanism for the dementia-sparing effect of PCI can only
be speculated on as this is an observational study. There is a large
but controversial literature, as to whether or not neuropsycho-
metric impairment occurs, following CABG; see references [30–
35]. The literature relating cognitive impairment following PCI is
much more sparse. However, one retrospective cohort analysis in
Veterans Affairs patients comparing the emergence of Alzheimer’s
disease following CABG (n=5,216) or PCI (n=3,954) indicated
an adjusted risk for dementia of 1.71 for CABG compared to
patients treated with PCI; a greater sparing effect for PCI than we
observed [36].
Recent work by Selnes and colleagues [5] indicates that there is
no difference in cognitive performance over time in patients with
IHD treated by CABG (either on-pump or off-pump) or managed
Table 2. Proportional Hazards Regression for Covariates of
Dementia.
Hazard 95% Confidence Limits p-value
Ratio Lower Upper
Age 1.07 1.07 1.07 ,0.0001
Diabetes 1.75 1.63 1.87 ,0.0001
Hypertension 2.93 2.74 3.13 ,0.0001
Sex 1.10 1.04 1.17 0.017
Income 0.99 0.98 1.00 0.100
doi:10.1371/journal.pone.0017457.t002
Table 3. Proportional Hazards Regression for Covariates of
Depression.
Hazard 95% Confidence Limits p-value
Ratio Lower Upper
Age 0.99 0.98 0.99 ,0.0001
Diabetes 1.31 1.25 1.40 ,0.0001
Hypertension 2.39 2.27 2.53 ,0.0001
Sex 1.62 1.54 1.71 ,0.0001
Income 0.99 0.98 1.00 0.99
doi:10.1371/journal.pone.0017457.t003
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groups. The study by Selnes et al. did not investigate patients
undergoing PCI as a management strategy. Their work also
documents that patients with IHD had lower baseline cognitive
performance when compared to healthy heart subjects and had
more rapid cognitive deterioration over a 72-month observation
period. Other than as noted above, few studies have directly
assessed neurocognitive function after PCI and compared this to
either CABG or medical management alone. Small, inconclusive
studies have been done by Sweet et al. [37] and Rosengart et al.
[38].
That patients with coronary artery disease have an increased
risk of cognitive decline is, in itself, controversial. Some studies
show a relationship [3,4,39] while others do not [18–20]. Some
clarification is advanced by the recently published Whitehall II
study. In a large cohort of civil servants (10,308 subjects) a
diagnosis of coronary heart disease was associated with decreased
cognitive performance in mid-life. Cognitive function was serially
assessed out to a period of ten years. When adjusted for age,
education, marital status and medication for cardiovascular
disease, a significant decline in reading, vocabulary and mini-
mental-state-examination (MMSE) was seen when compared to
those without a diagnosis of IHD. While the study highlights the
impact of IHD on long-term cognitive ability, the paper does not
address the impact of the management approach to IHD and its
potential effects on cognition.
The Whitehall II study further highlights the importance of
considering the ‘‘life-long’’ view of dementia. As emphasized,
coronary artery disease typically manifests in mid-life with dementia
occurring in later life but with a longpreclinical phase.[16]As in the
Whitehall II study, our observational study does not provide
mechanisms to account forthe identified correlation of heart disease
with dementia. Potential, but unexamined advantages associated
withPCImanagement of IHDinlimiting dementiamay includethe
following, but must be considered speculative [40]: 1) a lower
occurence of congestive heart failure; 2) better control of ischemic
arrhythmias; 3) a lower frequency of strokes and transient ischemic
attacks; 4) more frequent carotid endarterectomy in a group of
patients already pre-selected into an interventional stream, or; 5)
greater exercise-initiated rehabilitation with interventional ap-
proaches. In the SYNTAX trial, patients managed with PCI had
a lower rate of stroke in a 12-month follow-up period (0.6% for PCI
vs. 2.2% for CABG; p=0.003) [41].
Recent work indicates that lowered cardiac output, independent
of cardiac failure, is associated with brain aging as assessed by
neurocognitive testing and MRI-based neuroimaging markers
predictive of preclinical Alzheimer’s disease: decreased learning/
memory, decreased measured whole brain and hippocampal
volumes and cerebral ventricular enlargement [22]. A body of
work suggests a vascular hypothesis of Alzheimer’s disease in that
chronic brain hypoperfusion perhaps over decades can contribute
to cognitive impairment [42–44]. These results presuppose that
lowered cardiac output affects cerebral perfusion and that cerebral
autoregulation is not fully compensatory. In support of this
concept is animal work where perfusion pressure was changed
solely by altering pump flow to eliminate independent effects of
vasopressors or vasodilators on the cerebral circulation which
demonstrated attenuated autoregulation during normothermic
perfusion [45]. Complete revascularization of the heart increases
cardiac output following PCI [46]. One small study demonstrates
superior left ventricular function in left main disease for PCI vs
CABG [47]. Improved left ventricular performance, following
CABG has been clearly demonstrated by some [48,49]. More
equivocal results have also been obtained following CABG in
another study [50]. In this study by Diller and colleagues, left
ventricular ejection velocities declined to preoperative values by 18
months, with persistent right ventricular dysfunction. Ultimately, a
clear advantage for better left ventricular function and improved
cardiac output following PCI compared to CABG is not truly
evident from the above work.
On balance, a specific mechanism to account for the dementia-
sparing effect of PCI remains elusive. It is more likely that a series
of mechanisms play a part. Small net improvements of cardiac
output may interplay with a lowered rate of cognitive deterioration
seen with this approach as a mode of cardiac revascularization, but
controversy attends these considerations. The possibility that the
findings presented represent an epiphenomenon must also be
considered.
It is well established that depression can impact on the nature
and severity of IHD (see recent reviews) [51,52]. There is scant
literature on the question addressed here – new depression
following interventional approaches to management of IHD versus
medical management alone. Following CABG, readmission to
hospital was correlated to pre-operative anxiety states and post-
operative depression as assessed by questionnaire [53]. Amongst
our 3 groups, CABG was associated with the greatest risk of
depression. A lesser risk was also seen with PCI. As our study is
observational, based on administrative data, we cannot comment
on the severity of the depression, its mechanisms, nor its resolution
with therapy. Our findings suggest that a diagnosis of new
Table 4. Patient Outcome Hazard Ratios.
Hazard
Ratio
95% Confidence Limits
Lower Upper p-value
PCI vs IHD Medical
Dementia 0.65 0.46 0.84 0.017
Depression 1.26 1.04 1.53 0.028
CABG vs IHD Medical
Dementia 0.90 0.72 1.12 0.372
Depression 1.32 1.15 1.51 0.0001
PCI vs CABG
Dementia 0.74 0.49 1.12 0.15
Depression 0.96 0.76 1.21 0.71
doi:10.1371/journal.pone.0017457.t004
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17% for the full cohort studied. Treatment of depression in
patients with IHD may provide long-term improved quality of life
[54,55]. Our finding of an inverse relationship between advancing
age and the occurrence of depression has previously been
documented for the Province of Manitoba in the MCHP database,
by Martens et al. [26].
One of the strengths of our study is its long follow-up time. We
have followed patients for a minimum of three years and to a
maximum of 8 years after the diagnosis of IHD to identify
dementia and depression.
Limiting other end-organ damage with interventional ap-
proaches to IHD is now especially important as new evidence is
suggesting that CABG may be superior to stent insertion for
managing IHD [41,56]. Our data, in part, further address this
issue. The quality of coronary revascularization was noticeably
better with CABG compared to PCI, with a 16-fold lower rate of
subsequent open-heart surgery following an initial bypass
procedure and a 22-fold lower rate of subsequent PCI. Other
recent work has also indicated that CABG was superior to PCI for
myocardial revascularization in a non-inferiority study [41]. Our
study suggests ever greater superiority for CABG over PCI. The
difference, in part, relates to our follow-up time of up to 8 years vs
the SYNTAX trial follow-up of 12 months. We cannot comment
on whether or not some of the follow-up PCI interventions may
have been deliberately planned as staged procedures. An
argument advanced is that PCI should be considered for more
frail patients; however, the recent work by Hannan et al. [56]
indicates that their CABG patients had greater cardiac and other
end-organ disease pre-operatively.
We acknowledge that our finding regarding the dementia-
sparing effect of PCI is controversial and provocative. Follow-up
studies that are able to control for disease and outcome severity,
especially prospective ones to confirm or refute these findings are
required. We show that PCI as an interventional approach
decreases the likelihood of dementia in patients with documented
IHD. If our results are confirmed the means chosen to manage
IHD may influence the frequency of dementia and as a
consequence the quality of life in long-term survivors in this
patient population. Our study suggests that there are both cardiac
and cerebral benefits to interventional management of IHD. The
optimal approach to manage patients with IHD may now need to
balance the approach for long-term revascularization of the heart
to the differing long-term attenuation of dementia that occurs with
a chosen interventional approach. This study suggests that
prospective comparative effectiveness research [57] is warranted
to answer the issues raised.
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